Amlodipine is an oral dihydropyridine calcium channel blocker. Amlodipine is available as amlodipine besylate, initially approved in 1987 by the Food and Drug Administration (FDA).

**FDA-approved Indications**

- Hypertension**-**Amlodipine is an excellent first-line choice among the multiple options of antihypertensive agents. It may be used alone or in combination with other antihypertensive agents.

- Chronic Stable Angina - Amlodipine is indicated for the symptomatic treatment of chronic stable angina. Amlodipine may be used alone or in combination with other antianginal agents.

- Vasospastic Angina (Prinzmetal or Variant Angina) - Amlodipine is indicated to treat confirmed or suspected vasospastic angina.

- Angiographically Documented Coronary artery disease(CAD) - In patients with recently documented CAD by angiography and without heart failure or an ejection fraction <40%, Amlodipine is indicated to reduce the risk of hospitalization from angina and reduce the risk of a coronary revascularization procedure.

**Non-FDA-approved Indications**

- Diabetic nephropathy

- Left ventricular hypertrophy

- Raynaud phenomenon

- Silent myocardial ischemia

- Group 1 pulmonary arterial hypertension(PAH)- Use only in idiopathic PAH patients with positive vasodilator testing.